Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics - Wikidata - awgldk - TriplyDB

Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics

Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics

http://www.wikidata.org/entity/Q35175451

about

Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes.Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis.Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.Environmentally responsive MRI contrast agents.Dendrimers as high relaxivity MR contrast agents.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.The evolution of gadolinium based contrast agents: from single-modality to multi-modality.Quantification of the plasma clearance kinetics of a gadolinium-based contrast agent by photoinduced triplet harvesting.Polynuclear Sm(III) polyamidoamine-based dendrimer: a single probe for combined visible and near-infrared live-cell imaging.A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.Dendritic polymers for dermal drug delivery.Biosynthetic support based on dendritic poly(L-lysine) improves human skin fibroblasts attachment.Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.The precise molecular location of gadolinium atoms has a significant influence on the efficacy of nanoparticulate MRI positive contrast agents Gold: a versatile tool for in vivo imaging Magnetic hyperthermia of breast cancer cells and MRI relaxometry with dendrimer-coated iron-oxide nanoparticles

P2860

Q30820441-6CA75D63-F0FE-4661-852F-5A0423E72A76 Q30924405-736E40F5-D5BC-44DF-9243-746ADC98AC70 Q34161103-845FEDAB-0F17-4149-A83E-23231147CEDE Q35795478-AF2ED287-4A45-4E15-BC22-CE923DAD20B9 Q38090392-E707CD86-B7C9-434E-B70E-5B595B238193 Q38138098-89C7B165-A412-426F-B190-8AE50CB4D2B7 Q38155137-3D4803AC-D21F-4A8D-BB4B-3DDD4CA0D135 Q38155457-FFD1B402-4D8C-423A-997F-82C739C590F2 Q38809792-B0C9FE31-ABF4-484F-AC9E-8C1E355BB490 Q38829707-301E45B6-4D08-4281-9BA4-D69280AAFB24 Q41779796-C3A64B89-B32B-417E-B9F1-77E8C266F44B Q42804838-69E0607E-3C0B-426D-BAD6-DB449F91088F Q47866518-89814087-3678-46B8-BF35-18E0CDFF4985 Q50073512-9243FF40-40E8-4104-815B-22CD45EEA18C Q54779709-373214AE-28B7-40BF-B7FF-E144B3388EB2 Q54963271-D08190E8-C7D8-4E35-9A0D-99E5318C21B2 Q55073008-0461BB36-D608-4B1D-9031-0AF8A80FEA02 Q57367797-581938A3-450F-40B9-BB7D-45570C8B54BA Q58210360-4CDFCB06-6A35-4D87-A227-EBF3088E1C20 Q58578592-9515C262-BA5E-47DF-A22E-F3ABA66A03A1

P2860

Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics

http://www.wikidata.org/entity/Q35175451

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@ast

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@en

type

label

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@ast

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@en

prefLabel

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@ast

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@en

P1433

Q35175451-2390A390-299F-48B8-8FA3-A3CD458E74A3

P1476

Q35175451-029F3065-C164-41FB-BFA7-B097547918FC

P2093

Q35175451-3A7AD2B9-1F8F-48D0-B761-00F2D387C15E

Q35175451-3E04B23E-C309-400C-BD64-8FDE39C8947B

Q35175451-47273BFE-6010-4AA1-A5B9-99209EB49A6C

Q35175451-5E46B595-766A-4308-9DF6-2C15344A579D

Q35175451-7EDD59E7-ABDC-43D1-9AC9-F170ED926AF9

Q35175451-98909A53-7653-4DCE-AB9F-B7E719A0D01A

Q35175451-AEC48115-7BCE-4880-9620-541B6F69A232

Q35175451-F204D68B-D82E-4332-A70D-02E9AA41D3DC

Q35175451-F5EC54BE-7144-4B4B-A1BD-7643F1839724

P2860

Q35175451-0E28BF4D-6816-43C0-8243-5CF91B7C1E71

Q35175451-11934211-B649-44CC-BEA2-AFB2ADC157AA

Q35175451-16D32262-F732-476E-8EA1-C9250FFE510B

Q35175451-1D8B7FA1-04FC-4D8C-A877-7E8672235144

Q35175451-251410B2-4022-4148-96CC-0C379AA6F4F0

Q35175451-2682F455-9A49-4424-876A-48087D83550F

Q35175451-29D0F8AF-EAF3-4F2F-9FEC-5BEEC0CF5666

Q35175451-2EFE05A4-4D65-40F8-9353-8924851EF76E

Q35175451-3363A96B-768A-4D31-8774-D4D39DF9F243

Q35175451-33B5CF8B-0A62-453A-8259-2A58DE98A1C0

P304

Q35175451-C760E371-C20A-4145-9A38-05851A207767

P31

Q35175451-D9B43DD8-BA24-48C0-9672-E38C4B15CAD2

P356

Q35175451-F4199992-DCD1-49D5-9786-1E7672C7BF35

P433

Q35175451-98B02118-A185-476F-A4B8-613915C852EA

P478

Q35175451-50DE7F4E-BF25-486F-9F68-5083116183F2

P577

Q35175451-F75109E9-9C95-4C04-97E3-0CFC9ABA13DB

P5875

Q35175451-02162C55-B7D6-4FAF-8D8B-21139B4A2870

P698

Q35175451-905D2FAC-F163-4237-9F3D-1C00BE6A1C1C

P932

Q35175451-8C457850-6AA6-444B-8913-1AFA03617C04

P356

J.NANO.2011.03.007

P1433

Nanomedicine: Nanotechnology, Biology and Medicine

P1476

Dendrimer-based MRI contrast a ...... elaxivity and pharmacokinetics

@en

P2093

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Celeste A S Regino

http://www.w3.org/2001/XMLSchema#string

Chie Kojima

http://www.w3.org/2001/XMLSchema#string

Hisataka Kobayashi

http://www.w3.org/2001/XMLSchema#string

Kenji Kono

http://www.w3.org/2001/XMLSchema#string

L Henry Bryant

http://www.w3.org/2001/XMLSchema#string

Marcelino Bernardo

http://www.w3.org/2001/XMLSchema#string

Mikako Ogawa

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

P2860

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models

PAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: the interplay of global motion, internal rotation, and fast water exchange.

Physicochemical and MRI characterization of Gd3+-loaded polyamidoamine and hyperbranched dendrimers.

New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules

Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review.

Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.

Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine.

Designing dendrimers for biological applications.

Dendrimer-based contrast agents for molecular imaging

P304

1001-1008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NANO.2011.03.007

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51072442

http://www.w3.org/2001/XMLSchema#string

P698

21515406

http://www.w3.org/2001/XMLSchema#string

P932

3159711

http://www.w3.org/2001/XMLSchema#string